Oman vs Rwanda: Death rate from Parkinson's disease
Oman
1.5 deaths per 100,000 people
in 2021
Rwanda
1.45 deaths per 100,000 people
in 2021
Oman rank
139th
Rwanda rank
141st
Death rate from Parkinson's disease over time
- Oman
- Rwanda
How they compare
Oman currently reports 1.5 deaths per 100,000 people against 1.45 deaths per 100,000 people in Rwanda, a difference of 0.05 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Oman ahead.
Oman ranks 139th and Rwanda ranks 141st of 194 countries.
Across the 3 decades both report, Oman averaged higher in 2 and Rwanda in 1.
Head to head by decade
| Decade | Oman | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.38 deaths per 100,000 people | 1.55 deaths per 100,000 people | 0.166 deaths per 100,000 people | Rwanda |
| 2010s | 1.62 deaths per 100,000 people | 1.58 deaths per 100,000 people | 0.04 deaths per 100,000 people | Oman |
| 2020s | 1.73 deaths per 100,000 people | 1.44 deaths per 100,000 people | 0.285 deaths per 100,000 people | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Oman or Rwanda?
- Oman, at 1.5 deaths per 100,000 people against 1.45 deaths per 100,000 people in Rwanda as of 2021.
- What is the difference in death rate from parkinson's disease between Oman and Rwanda?
- 0.05 deaths per 100,000 people, with Oman ahead.
- How many years of comparable data are there for Oman and Rwanda?
- 22 years are reported by both, from 2000 to 2021.
- How do Oman and Rwanda rank globally for death rate from parkinson's disease?
- Oman ranks 139th and Rwanda ranks 141st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.